The estimated Net Worth of Mezerville Roberto De is at least 6.55 百万$ dollars as of 21 May 2021. Mr. De owns over 3,866 units of Establishment Labs Inc stock worth over 4,428,724$ and over the last 6 years he sold ESTA stock worth over 2,117,935$. In addition, he makes 0$ as Chief Technology Officer at Establishment Labs Inc.
Sign up
Mr. Mezerville ESTA stock SEC Form 4 insiders trading
Roberto has made over 6 trades of the Establishment Labs Inc stock since 2020, according to the Form 4 filled with the SEC. Most recently he sold 3,866 units of ESTA stock worth 290,955$ on 21 May 2021.
The largest trade he's ever made was selling 10,934 units of Establishment Labs Inc stock on 18 May 2021 worth over 813,380$. On average, Roberto trades about 4,979 units every 41 days since 2018. As of 21 May 2021 he still owns at least 108,044 units of Establishment Labs Inc stock.
You can see the complete history of Mr. De stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Roberto De Mezerville biography
Roberto De Mezerville serves as Chief Technology Officer of the Company. Mr. Mezerville has held positions of increasing responsibility at our company since 2009 in the areas of quality management, research and development, innovation and regulatory and clinical affairs and has been our Vice President of Quality and R&D since June 2015. From 2006 to 2009, Mr. Mezerville served in various engineering and quality manager positions with Allergan Medical Costa Rica. He has a Bachelor’s Degree in Business Administration from Universidad Interamericana de Costa Rica and a Bachelor’s degree in Industrial Environmental Health and Safety Engineering from Instituto Tecnologico de Costa Rica.
How old is Roberto Mezerville?
Roberto Mezerville is 39, he's been the Chief Technology Officer of Establishment Labs Inc since 2018. There are 11 older and 4 younger executives at Establishment Labs Inc. The oldest executive at Establishment Labs Holdings Inc is Dennis Condon, 83, who is the Independent Director.
What's Roberto Mezerville's mailing address?
Mezerville's mailing address filed with the SEC is C/O MOTIVA USA LLC, 16192 COASTAL HIGHWAY, LEWES, DE, 19958.
Insiders trading at Establishment Labs Inc
Over the last 6 years, insiders at Establishment Labs Inc have traded over 8,492,826$ worth of Establishment Labs Inc stock and bought 169,894 units worth 9,905,657$ . The most active insiders traders include David Hung、Nicholas Sheridan Lewin、Quiros Juan Jose Chacon. On average, Establishment Labs Inc executives and independent directors trade stock every 34 days with the average trade being worth of 513,072$. The most recent stock trade was executed by Quiros Juan Jose Chacon on 11 July 2024, trading 3,641 units of ESTA stock currently worth 163,991$.
What does Establishment Labs Inc do?
establishment labs is a global, privately held, high-tech medical device and aesthetics company that designs, develops, manufactures and markets an innovative product portfolio consisting of advanced silicone-filled breast and body shaping implants. with more than 30 years of advanced breast implant manufacturing experience, building quality breast implants has always been a natural outcome for establishment labs’ founders and top executives. as a result, motiva implants® has established a level of product innovation that always results in safety. and while we respect our past, we ́re more focused on the present and the future, one that ́s innovative, safe and progressive. we believe that these goals can be achieved by incorporating the current needs and preferences of plastic surgeons and patients into our product design.
What does Establishment Labs Inc's logo look like?
Complete history of Mr. De stock trades at Establishment Labs Inc
Establishment Labs Inc executives and stock owners
Establishment Labs Inc executives and other stock owners filed with the SEC include:
-
Juan Jose Chacon Quiros,
Founder, CEO & Exec. Director -
Juan Jose Chacon Quiros,
Chief Executive Officer, Director -
Salvador Santos Dada,
Chief Operating Officer (Medical Leave of Absence) -
Renee Gaeta,
Chief Financial Officer -
Salvador Santos,
Chief Operating Officer -
Eddie De Oliveira,
Vice President of Sales Latin America -
David Erickson,
IR Contact Officer -
Edward Schutter,
Independent Director -
David Hung,
Independent Director -
Lisa Gersh,
Independent Director -
Dennis Condon,
Independent Director -
Lisa Colleran,
Independent Director -
Jeremy Livianu,
General Counsel -
Alberto Quesada,
Vice President - Quality & OUS Regulatory Affairs -
Roberto De Mezerville,
Chief Technology Officer -
Nicholas Lewin,
Chairman of the Board -
Roberto de Mezerville,
Chief Technology Officer -
Rosalyn Cole d'Incelli,
VP of Clinical & Medical Affairs -
Eddie De Oliveira,
VP of Sales, Brazil -
Dr. Heather Brennan,
Head of U.S. Commercial Operations -
Jeffrey Clark Bettinger,
Global Head of People -
Neeta Toprani,
Gen. Counsel & Corp. Sec. -
Roberto De Mezerville,
Chief Technology Officer -
Pratip Dastidar,
Head of Global Operations -
Rajbir Singh Denhoy,
CFO and Head of Strategy & Investor Relations -
Paul D. Rodio,
Chief Operating Officer -
Tu, Lp Cph,
10% owner -
Asset Management, Llcjw Par...,
-
Pratip Dastidar,
Head of Global Operations -
Ann Custin,
Director -
Bryan Slotkin,
Director -
Leslie Gillin,
Director -
Raj Denhoy,
Chief Financial Officer -
Samuel Ross Mansbach,
-
Filippo Caldini,
President